MIT Enterprise Forum of Cambridge Presents Medical Device Technology Case Studies: Exploring Marketing and Distribution Challenges.MIT MIT - Massachusetts Institute of Technology Enterprise Forum of Cambridge-- What: On April 18th, the MIT Enterprise Forum of Cambridge will host discussions at the cutting edge of medical technology and innovation. The program will begin with a keynote address by John McDonough of Cytyc Corporation, discussing one company's challenges in introducing innovative technology that displaces a long-established medical system. A case presentation led by Lydia Villa-Komoroff, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Cytonome, will explore the decisions facing a medical device company as it introduces a new technology and strives to gain market acceptance. A panel of experts features McDonough along with John Brooks, a partner at Prism VentureWorks, and Jerome Ritz, M.D. of Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts. and the Dana-Farber Cancer Institute. The night will be moderated by Richard B. Smith, a partner at Edwards Angell Palmer & Dodge LLP LLP - Lower Layer Protocol . Speakers: Keynote Speaker: McDonough is the senior vice president of corporate development and operations at Cytyc Corporation. He is responsible for the development and execution of Cytyc's merger and acquisition strategy, development and marketing alliances and venture investing. Since joining Cytyc in 2003, he has lead the successful acquisition and integration of several companies that now contribute over 35 percent of Cytyc's annual revenue. Before coming to Cytyc, McDonough served as co-founder, CEO and president at SoundBite Communications, a customer communications company. Case Presenter: Dr. Villa-Komaroff is the CEO at Cytonome, a provider of clinical grade optical cell sorting technology. Dr. Villa-Komaroff has held positions at MIT, Harvard University, the University of Massachusetts Medical School UMMS is ranked fourth in primary care education among the nation’s 125 medical schools in the 2006 U.S.News & World Report annual guide, “America’s Best Graduate Schools”. UMMS is also a major center for research. and Harvard Medical School. As a science administrator, she has been VP for research at Northwestern University and VP for research and CEO of Whitehead Institute for Biomedical Research in Cambridge, MA. Panelists: John Brooks is a founding partner at Prism VentureWorks and is a member of the integral life sciences team. Brooks invests in medical device, drug delivery and drug discovery companies. He currently sits on the boards of OmniSonics, OptiScan Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. , Peptimmune, Confirma, MedManage Systems and Uptake Medical. Dr. Ritz is Professor of Medicine at Harvard Medical School and a senior physician in the Stem Cell Transplantation Stem Cell Transplantation Definition Stem cells are basic human cells that reproduce (replicate) easily, providing a continuous source of new, sometimes different types of cells. Program at the Dana-Farber Cancer Institute and Brigham and Women's Hospital Brigham and Women's Hospital (BWH) is a hospital in the Longwood Area of the Boston, Massachusetts neighborhood of Mission Hill. With Massachusetts General Hospital, it is one of the two founding members of Partners HealthCare. . He is the Director of the Cell Manipulation Core Facility of the Dana-Farber/Harvard Cancer Center Dana-Farber/Harvard Cancer Centeris the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1998, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community. . His laboratory research has focused on ways to improve the recovery of immune function after stem cell transplantation. The panel moderator will be Richard B. Smith, a partner at Edwards Angell Palmer & Dodge LLP. Smith concentrates his practice on strategic business collaborations for biotechnology and biomedical device companies typically involving licensing, marketing, supply and co-promotion transactions. He also advises on corporate issues common to technology companies, including venture capital financing To start an own company or to bring a new product to the market, the venture may need to attract financial funding. There are several categories of financing possibilities. If it is a small venture, then perhaps the venture can rely on family funding, loans from friends and all business aspects of intellectual property law.
When: Wednesday, April 18, 2007
Networking: 5:30 p.m.
Program: 6:15-8:30 p.m.
Networking: 8:30-9:30 p.m.
Where: Stata Center (Bldg. 32), Kirsch Auditorium
1st floor, 32 Vassar Street, Cambridge
Sponsor: Edwards Angell Palmer & Dodge
Registration and information: http://www.mitforumcambridge.org/april07.html Forum members: $20; Non-members: $30; Students from all universities, free with college ID. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion